Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mitochondrial ATP-sensitive potassium channel (mitoKATP) is an ion channel located in the inner mitochondrial membrane. It regulates the influx of potassium ions (K+) into mitochondria in response to intracellular ATP levels, thereby linking cellular energy status to mitochondrial function. It is composed of MITOK (pore-forming) and MITOSUR (regulatory/ATP-binding) subunits. By controlling K+ influx, mitoKATP channels help maintain mitochondrial membrane potential and volume homeostasis, supporting continued oxidative phosphorylation and preventing excessive swelling or depolarization during metabolic stress. Activation of mitoKATP channels has been shown to protect cells—especially cardiac myocytes—against ischemia-reperfusion injury. Pharmacologically targeted by agents such as diazoxide (activator) for cardioprotection.
Activation of mitoKATP channels
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial ATP-Sensitive Potassium Channel (mitoKATP).